Research programme: apoptosis stimulants - Tripos/MDS/Cell Pathways
Alternative Names: Apoptosis stimulants research programme - Tripos/MDS/Cell PathwaysLatest Information Update: 01 Aug 2001
At a glance
- Originator MDS Pharma Services; Tripos
- Developer Cell Pathways; MDS Pharma Services; Tripos
- Class
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 01 Aug 2001 Discontinued-Preclinical for Cancer in Canada (Unknown route)
- 01 Aug 2001 Discontinued-Preclinical for Cancer in USA (Unknown route)
- 18 Mar 1998 Preclinical development for Cancer in Canada (Unknown route)